What Is IGF-1 and Why Does It Matter?
Insulin-like Growth Factor 1 (IGF-1) is a hormone with a molecular structure similar to insulin. It is one of the most potent natural activators of the AKT signaling pathway, which drives cell growth, proliferation, and survival.
Here is the simplified version of how it works:
- Your pituitary gland releases growth hormone (GH) in pulses, primarily during deep sleep and exercise
- GH travels to the liver, which produces approximately 75% of circulating IGF-1 in response
- IGF-1 enters the bloodstream and binds to IGF-1 receptors throughout the body
- This triggers anabolic signaling -- muscle protein synthesis, bone growth, tissue repair, and cellular regeneration
Think of GH as the signal and IGF-1 as the executor. GH tells the liver to make IGF-1, and IGF-1 does the actual work at the tissue level.
IGF-1 levels naturally peak during puberty (when you are growing fastest) and decline steadily after age 30 -- roughly 14% per decade according to data published in the Journal of Clinical Endocrinology & Metabolism. This age-related decline correlates with loss of muscle mass, increased body fat, slower recovery, reduced bone density, and diminished cognitive function.
The reference range for adult IGF-1 is typically 100-300 ng/mL, but optimal varies by age and individual context. Many longevity-focused clinicians target the upper third of the age-adjusted range -- enough to support anabolic processes without pushing into supraphysiological territory.
Maximizing Your Natural IGF-1 Production
Before even considering exogenous options, there is a surprising amount of headroom for most people to increase their endogenous IGF-1. Here are the levers, ranked by impact.
Sleep: The Primary GH/IGF-1 Driver
This shows up first because it is the single biggest factor.
Approximately 70-80% of your daily GH secretion occurs during slow-wave (deep) sleep. Since GH directly stimulates hepatic IGF-1 production, poor sleep means poor IGF-1 levels. It is that simple.
A study by Van Cauter et al. (2000) in JAMA demonstrated that men who slept 4 hours versus 8 hours had significantly blunted GH pulses and reduced IGF-1 signaling.
Action items:
- Prioritize 7-9 hours of quality sleep
- Optimize deep sleep specifically -- consistent bedtime, cool room (65-68F), dark environment, magnesium glycinate before bed
- Track sleep stages with a wearable to verify you are actually getting adequate deep sleep (aim for 15-20% of total sleep time)
Protein Intake: The Raw Material
IGF-1 production is highly sensitive to protein and caloric intake. This is a survival mechanism -- when food is scarce, your body downregulates growth signaling.
A 2003 study in the European Journal of Clinical Nutrition found that increasing protein intake from 0.7 to 1.4 g/kg/day significantly increased IGF-1 levels in healthy adults. The subjects eating more protein had IGF-1 levels approximately 20% higher than the lower-protein group.
The mechanism is straightforward: amino acids (particularly leucine) stimulate hepatic IGF-1 gene expression. If you are under-eating protein, you are leaving IGF-1 on the table.
Action items:
- Minimum 1.6g protein per kg bodyweight daily
- Ensure adequate total caloric intake -- chronic caloric restriction suppresses IGF-1
- Distribute protein across meals to maintain a consistent amino acid supply
- Dairy protein may be particularly effective -- casein and whey have shown independent IGF-1 elevating effects in epidemiological studies (Hoppe et al., 2004, European Journal of Clinical Nutrition)
Resistance Training: The Stimulus
Heavy resistance training is one of the most reliable acute stimulators of GH and, consequently, IGF-1.
A 2010 review in Sports Medicine by West and Phillips confirmed that resistance exercise produces significant acute elevations in GH lasting 15-30 minutes post-exercise. Compound movements (squats, deadlifts) using moderate to heavy loads (70-85% 1RM) with moderate rest periods (60-90 seconds) produced the largest GH responses.
But the chronic effect matters more than the acute spike. Consistent resistance training over months leads to sustained elevations in baseline IGF-1 levels. A 2007 study in Medicine & Science in Sports & Exercise found that 16 weeks of progressive resistance training increased resting IGF-1 by approximately 15% in previously untrained adults.
Action items:
- Train with resistance 3-5x per week
- Prioritize compound movements with progressive overload
- Include both moderate rep ranges (8-12) and heavier work (4-6 reps) for variety
- Do not neglect training volume -- more total working sets generally correlates with greater hormonal response
Liver Health: The Production Facility
Here is a factor that almost nobody talks about. Your liver produces the vast majority of circulating IGF-1. If your liver is not functioning optimally, your IGF-1 output will be compromised regardless of how much GH your pituitary releases.
Common liver stressors that can impair IGF-1 production:
- Alcohol consumption -- even moderate drinking (2+ drinks/day) is associated with reduced IGF-1 in several studies
- Non-alcoholic fatty liver disease (NAFLD) -- increasingly common, especially in metabolically unhealthy individuals. NAFLD is associated with significantly lower IGF-1 levels (Völzke et al., 2009, Journal of Hepatology)
- Hepatotoxic supplements -- high-dose NSAID use, certain herbal extracts, and some oral compounds stress the liver
- Excess body fat -- visceral fat accumulation drives hepatic inflammation
Action items:
- Minimize or eliminate alcohol
- Monitor liver enzymes (AST, ALT, GGT) via bloodwork
- Maintain a healthy body composition -- visceral fat is the enemy of liver health
- Consider liver-supportive compounds only after basics are addressed: adequate choline intake, moderate coffee consumption (data supports a hepatoprotective effect), and avoidance of hepatotoxic substances
Other Factors
- Vitamin D status -- deficiency is associated with lower IGF-1. A study by Ameri et al. (2013) in Nutrients found a positive correlation between Vitamin D levels and IGF-1 in adults. Target 40-60 ng/mL.
- Zinc -- essential cofactor for GH signaling. Deficiency impairs GH release and IGF-1 production. 15-30mg daily.
- Stress management -- chronic cortisol elevation suppresses GH secretion. This is mediated by cortisol's inhibitory effect on GHRH neurons in the hypothalamus.
When Researchers Look at Exogenous Options
After endogenous optimization is fully explored, some researchers turn to exogenous approaches to further elevate IGF-1. The primary options include:
GH Secretagogues (Indirect)
These stimulate your own GH production, which then raises IGF-1:
- MK-677 (Ibutamoren) -- oral ghrelin mimetic, raises IGF-1 by 40-60% in studies (see our MK-677 deep dive for full analysis)
- CJC-1295 + Ipamorelin -- injectable peptide combination that amplifies natural GH pulsatility
- Sermorelin -- GHRH analogue that stimulates pituitary GH release
These maintain the body's feedback loops, as IGF-1 elevation comes from enhanced endogenous GH.
Exogenous GH (Direct)
Recombinant human growth hormone (rhGH) directly provides GH, bypassing the pituitary. This reliably raises IGF-1 but introduces risks including:
- Potential suppression of natural GH production
- Insulin resistance (GH is counter-regulatory to insulin)
- Fluid retention, joint pain, carpal tunnel syndrome
- Cost ($500-2000+/month for pharmaceutical-grade)
Direct IGF-1 Administration
Recombinant IGF-1 (mecasermin, brand name Increlex) exists as an FDA-approved treatment for severe primary IGF-1 deficiency. It is not commonly used in the research community due to hypoglycemia risk and difficulty controlling levels.
The Risks of Supraphysiological IGF-1
More is not always better. This is critical to understand.
Chronically elevated IGF-1 above the reference range is associated with:
- Increased cancer risk -- IGF-1 promotes cell proliferation and inhibits apoptosis (programmed cell death). A meta-analysis by Renehan et al. (2004) in The Lancet found that higher circulating IGF-1 was associated with increased risk of prostate, colorectal, and premenopausal breast cancer
- Acromegaly-like symptoms -- joint pain, soft tissue swelling, organ enlargement at sustained supraphysiological levels
- Insulin resistance -- high IGF-1 can contribute to metabolic dysregulation
- Potential cardiovascular effects -- the relationship is complex, as moderate IGF-1 appears cardioprotective while very high levels may increase risk
The goal is not to maximize IGF-1 at all costs. The goal is to optimize it within a healthy range that supports recovery, muscle maintenance, and cellular function without tipping into the danger zone.
Monitoring Via Bloodwork
If you are actively working to optimize IGF-1, regular bloodwork is essential.
What to Test
- IGF-1 -- the primary marker. Lab reference ranges are age-adjusted.
- IGFBP-3 -- IGF-1 binding protein 3. Most circulating IGF-1 is bound to IGFBP-3. The IGF-1/IGFBP-3 ratio gives a better picture of bioavailable IGF-1.
- GH stimulation markers -- if IGF-1 is low despite optimized lifestyle, a GH stimulation test can determine if the issue is pituitary output or hepatic conversion.
- Fasting insulin and glucose -- monitor metabolic health alongside IGF-1 changes.
- Liver enzymes -- ensure the factory is healthy.
Testing Frequency
- Baseline before any protocol changes
- 6-8 weeks after implementing lifestyle or compound changes
- Every 3-6 months for ongoing monitoring
Interpreting Results
- IGF-1 consistently below the 25th percentile for your age despite optimized lifestyle warrants further investigation
- IGF-1 in the upper third of the age-adjusted range is generally considered optimal for performance and recovery
- IGF-1 consistently above the reference range increases oncological risk and warrants dose reduction or discontinuation of any exogenous support
The Bottom Line
IGF-1 optimization is a spectrum, not a binary. The vast majority of people have significant room to improve their natural IGF-1 levels through sleep, protein intake, resistance training, and liver health before any exogenous intervention is worth considering.
When the foundation is solid and bloodwork confirms that endogenous production has been maximized, then -- and only then -- does it make sense to evaluate whether exogenous support addresses a specific, documented gap. And even then, the goal should be optimization within a healthy range, not maximization at any cost.
Your body has powerful growth factor machinery built in. Use it fully before looking for external solutions.
Disclaimer: This article is for educational and informational purposes only and is not medical advice. IGF-1 and growth hormone optimization should be discussed with and monitored by a qualified healthcare provider. Exogenous GH and IGF-1 are prescription medications with significant risk profiles. CompoundIQ does not encourage or endorse the use of any substance outside of legal and medically supervised contexts.